GlassScriptPhysician profile
Damon B Combs
NPI 1588825947
$62,507.72
in general payments reported to CMS, 2019-2025
30 companies · $13K in 2025
The $13K reported for 2025 was more than what 96% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,121 · 2020: $5,340 · 2021: $2,373 · 2022: $1,133 · 2023: $5,741 · 2024: $32K · 2025: $13K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $18K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $9,520 · Honoraria: $8,120 · Royalty Or License: $6,112 · Travel and Lodging: $5,981 · Food and Beverage: $3,256.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,550.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $9,520.00 |
| Honoraria | $8,120.00 |
| Royalty Or License | $6,112.42 |
| Travel and Lodging | $5,981.33 |
| Food and Beverage | $3,256.45 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fusion Orthopedics USA, LLC | $16,753.94 | 2024-2025 | Small Bone 5th Met Hook Plate, Midfoot T Plate, Jones Headless Screws, Fuzefix |
| Royal Biologics, INC. | $11,885.11 | 2024 | |
| Organogenesis INC. | $10,916.52 | 2021-2025 | Puraply Wound Matrix, Puraply Antimicrobial, Nushield |
| Averitas Pharma INC. | $9,279.93 | 2023-2025 | Qutenza |
| Mid-Atlantic Surgical Systems, LLC | $6,321.11 | 2019-2021 | |
| Arthrex, INC. | $2,993.15 | 2020 | |
| Grt US Holding, INC. | $1,164.31 | 2020-2022 | |
| Fusion Orthopedics, LLC. | $1,033.48 | 2023-2024 | Polylock Small Bone, Polylock Midfoot, Fuzefix, Small Bone 5th Met Hook Plate, Midfoot T Plate, Jones Headless Screws |
| Curonix LLC | $361.09 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Bioventus LLC | $309.16 | 2019-2025 | Exogen Ultrasound Bone Healing System, Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $226.10 | 2021-2025 | Stravix, Stravix Mesh, Renasys Go V2 Home |
| Abbott Laboratories | $193.36 | 2019-2022 | |
| Pacira Pharmaceuticals Incorporated | $183.59 | 2019-2023 | Zilretta, Iovera, Exparel |
| Rmr Ortho INC | $169.23 | 2025 | A'Tomic |
| Osteomed LLC | $114.01 | 2021 |
Show all 30 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biotissue Holdings INC. | $99.33 | 2021 | |
| Stryker Corporation | $90.80 | 2019-2025 | Augment Injectable |
| Ethicon US, LLC | $87.19 | 2020-2025 | Monocryl, Harmonic, Enseal |
| Si-Bone, INC. | $53.89 | 2019-2022 | |
| Boston Scientific Corporation | $44.84 | 2025 | General - Pain Management |
| Vertex Pharmaceuticals Incorporated | $39.92 | 2025 | |
| Sanofi-Aventis U.S. LLC | $37.59 | 2022 | |
| Nevro Corp. | $27.44 | 2023 | Senza |
| Medtronic, INC. | $24.28 | 2025 | Inceptiv |
| Baudax Bio INC. | $24.26 | 2020 | |
| Depuy Synthes Sales INC. | $18.73 | 2025 | Orthovisc, Monovisc |
| Amniox Medical, INC. | $16.84 | 2020 | |
| Acera Surgical, INC. | $13.73 | 2023 | Restrata Wound Matrix |
| Amgen INC. | $13.50 | 2025 | Krystexxa |
| Access Pro Medical, LLC | $11.29 | 2023 | Matriderm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Damon Combs listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.